Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06729151 · ClinicalTrials.gov registry record
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
A clinical trial of Bladder Pain Syndrome and Female Sexual Dysfunction, sponsored by Walter Reed National Military Medical Center.
- Recruiting
- Registry status
- 159
- Enrollment target
- 1
- Study location
NCT06729151 is a study of Bladder Pain Syndrome and Female Sexual Dysfunction that is actively recruiting participants, run by Walter Reed National Military Medical Center. The registered enrollment target is 159 participants, roughly in line with the 158-participant average among 13 other Bladder Pain Syndrome trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06729151, a study of Bladder Pain Syndrome and Female Sexual Dysfunction, is actively recruiting participants, sponsored by Walter Reed National Military Medical Center.
- RECRUITING
- Registry status
- 159 participants
- Enrollment target
- 1
- Study location
Study Summary
Interstitial cystitis/bladder pain syndrome (IC/BPS) is estimated to affect 3.3 to 7.9 million women aged 18 years and older in the United States. The American Urological Association (AUA) defines IC/BPS as "an unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than six weeks duration, in the absence of infection or other identifiable causes". IC/BPS significantly impacts quality of life, with the individual domains of sexual function, anxiety and depression, sleep quality and work productivity being specifically affected. Significant sexual dysfunction in women with IC/BPS has been consistently demonstrated across multiple international studies, with a prevalence ranging from 68% to 91%. In fact, among all patients with lower urinary tract symptoms, patients with a diagnosis of IC/BPS had the highest levels of impaired sexual function, mostly due to dyspareunia. Recommended treatments for IC/BPS include dietary and behavioral modifications, oral medications, bladder instillations, bladder hydrodistension, intradetrusor injection of onabotulinumtoxinA and major surgery. Scant research exists on how treating IC/BPS affects sexual function. We are conducting a prospective cohort study to assess for improvement in sexual function following intravesical onabotulinumtoxinA injection versus conservative management for IC/BPS. The study will consist of three groups: intradetrusor onabotulinumtoxinA injection, conservative management and age-matched, healthy controls. All patients aged 18 years and older presenting to the Walter Reed National Military Medical Center (WRNMMC) Urogynecology clinic who are given a diagnosis of IC/BPS and have an O'Leary Sant index questionnaire scoring 13 or greater will be eligible for the study. The primary study outcome is change in the pre- and 12-week post-treatment Female Sexual Function Index (FSFI). The secondary outcomes will include c
Conditions Studied
Interventions
- DRUG Onabotulinum toxin A
- BEHAVIORAL Conservative management (dietary and behavioral)
Study Locations (1)
Maryland
- Walter Reed National Military Medical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06729151
The ClinicalTrials.gov registry entry for NCT06729151 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 158-participant average among 13 other Bladder Pain Syndrome trials with a reported enrollment target. The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bladder Pain Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Onabotulinum toxin A is the first listed.
NCT06729151 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06729151 about?
NCT06729151 is a clinical study titled "Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome". Interstitial cystitis/bladder pain syndrome (IC/BPS) is estimated to affect 3.3 to 7.9 million women aged 18 years and older in the United States. The American Urological Association (AUA) defines IC/BPS as "an unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary ...
What is the current status of trial NCT06729151?
This trial is currently recruiting. The enrollment target is 159 participants. The study started on 2024-11-01. Estimated completion is 2026-12-31.
What conditions does trial NCT06729151 study?
This clinical trial studies the following conditions: Bladder Pain Syndrome, Female Sexual Dysfunction.
What interventions are being tested in trial NCT06729151?
The interventions under investigation include: Onabotulinum toxin A (DRUG), Conservative management (dietary and behavioral) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06729151?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06729151 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Pain Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome
RECRUITING · NA
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
Identifying Genetic Causes of IC/BPS
RECRUITING
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.